Evidence map›Paper›PMID 26478470›Full record

ArticleActa biomaterialia2016

Production of ascorbic acid releasing biomaterials for pelvic floor repair.

Naşide Mangır, Anthony J Bullock, Sabiniano Roman, Nadir Osman, Christopher Chapple, Sheila MacNeil

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tissue-engineered repair material for pelvic floor dysfunction.Frontiers in bioengineering and biotechnology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Naşide MangırDepartment of Materials Science Engineering, Kroto Research Institute, University of Sheffield, United Kingdom; Royal Hallamshire Hospital, Urology Clinic, Sheffield, United Kingdom.
Anthony J BullockDepartment of Materials Science Engineering, Kroto Research Institute, University of Sheffield, United Kingdom.
Sabiniano RomanDepartment of Materials Science Engineering, Kroto Research Institute, University of Sheffield, United Kingdom.
Nadir OsmanDepartment of Materials Science Engineering, Kroto Research Institute, University of Sheffield, United Kingdom; Royal Hallamshire Hospital, Urology Clinic, Sheffield, United Kingdom.
Christopher ChappleRoyal Hallamshire Hospital, Urology Clinic, Sheffield, United Kingdom.
Sheila MacNeilDepartment of Materials Science Engineering, Kroto Research Institute, University of Sheffield, United Kingdom. Electronic address: s.macneil@sheffield.ac.uk.
Royal Hallamshire Hospital · GBUniversity of Sheffield · GB

Funding

Medical Research Council MR/K026682/1
6 · The paper itself

Abstract

objectiveAn underlying abnormality in collagen turnover is implied in the occurrence of complications and recurrences after mesh augmented pelvic floor repair surgeries. Ascorbic acid is a potent stimulant of collagen synthesis. The aim of this study is to produce ascorbic acid releasing poly-lactic acid (PLA) scaffolds and evaluate them for their effects on extracellular matrix production and the strength of the materials. MATERIALS AND

methodsScaffolds which contained either l-ascorbic acid (AA) and Ascorbate-2-Phosphate (A2P) were produced with emulsion electrospinning. The release of both drugs was measured by UV spectrophotometry. Human dermal fibroblasts were seeded on scaffolds and cultured for 2weeks. Cell attachment, viability and total collagen production were evaluated as well as mechanical properties.

resultsNo significant differences were observed between AA, A2P, Vehicle and PLA scaffolds in terms of fibre diameter and pore size. The encapsulation efficiency and successful release of both AA and A2P were demonstrated. Both AA and A2P containing scaffolds were significantly more hydrophilic and stronger in both dry and wet states compared to PLA scaffolds. Fibroblasts produced more collagen on scaffolds containing either AA or A2P compared to cells grown on control scaffolds.

conclusionThis study is the first to directly compare the two ascorbic acid derivatives in a tissue engineered scaffold and shows that both AA and A2P releasing electrospun PLA scaffolds increased collagen production of fibroblasts to similar extents but AA scaffolds seemed to be more hydrophilic and stronger compared to A2P scaffolds. STATEMENT OF SIGNIFICANCE: Mesh augmented surgical repair of the pelvic floor currently relies on non-degradable materials which results in severe complications in some patients. There is an unmet and urgent need for better pelvic floor repair materials. Our current understanding suggests that the ideal material should be able to better integrate into sites of implantation both biologically and mechanically. The impact of vitamin C on extracellular matrix production is well established but we in this study have undertaken a critical comparison of two derivatives of vitamin C as they are released from a biodegradable scaffold. This strategy proved to be equally useful with both derivatives in terms of new tissue production yet we observed significant differences in mechanical properties of these biomaterials.

Indexed as

Ascorbic AcidLactic AcidPelvic FloorPolymersSurgical MeshCells, CulturedDelayed-Action PreparationsFibroblastsHumansPolyestersTissue ScaffoldsAscorbic AcidDelayed-Action PreparationsLactic AcidPolyesterspoly(lactide)PolymersCollagenExtracellular matrixPelvic floor tissue engineeringPolylactic acid

Identifiers

PMID26478470
PMCPMC4678952
OpenAlexW1875687721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.